Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.617, 2010-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 652, 2012-01 ,pp. :
Access to resources
Recommend
Sunitinib gets the gist in imatinib-resistance
Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. :
Imatinib for priority review by US FDA for GIST recurrence.
Inpharma, Vol. 1, Iss. 1654, 2008-01 ,pp. :
Imatinib for 3 years − getting a grip on GIST
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 666, 2012-01 ,pp. :
Epoetin- in heart surgery patients - not worth the cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :